-
HOSPITAL BUDGET IMPACT MODEL OF TV-46000, A LONG-ACTING SUBCUTANEOUS FORMULATION OF RISPERIDONE, VERSUS ONCE-MONTHLY PALIPERIDONE PALMITATE IN ADULTS WITH SCHIZOPHRENIA IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SELF-SELECTION AND THE DECISION TO PARTICIPATE IN CLINICAL TRIALS:EVIDENCE FROM LUNG CANCER SCREENING TRIALS
Mar 18, 2026, 21:38 PM -
RISK OF SEVERE GASTROINTESTINAL EVENTS IN COMMERCIALLY INSURED PATIENTS INITIATING GLP-1RAS FOR DIABETES MELLITUS AND OBESITY: A TARGET TRIAL EMULATION STUDY
Mar 18, 2026, 21:38 PM -
TYPE OF INSURANCE COVERAGE AND AFFORDABILITY BARRIERS IN MEDICAL, DENTAL, AND PRESCRIPTION SERVICES AMONG ADULTS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
HEALTH-ECONOMIC VALUE OF A NOVEL ANASTOMOSIS PROTECTION DEVICE AFTER COLORECTAL RESECTION: AN ANALYSIS BASED ON THE SAFE-2025 STUDY AND U.S. CLAIMS DATA
Mar 18, 2026, 21:38 PM -
ESTIMATING STATE- AND COUNTY-LEVEL CHRONIC DISEASE AND RISK FACTOR PREVALENCE: VALIDATING A SYNTHETIC POPULATION APPROACH USING NATIONALLY REPRESENTATIVE SURVEY DATA
Mar 18, 2026, 21:38 PM -
COMPARATIVE ANALYSIS OF RISK FACTORS AND SHORT-TERM OUTCOMES AFTER PRIMARY PCI IN PRE- AND POST-MENOPAUSAL WOMEN WITH STEMI EXPERIENCE FROM LMIC
Mar 18, 2026, 21:38 PM -
A UNITED STATES BUDGET IMPACT ANALYSIS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN THE TREATMENT OF INADEQUATELY CONTROLLED ASTHMA
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF EARLY DIAGNOSIS AND TREATMENT FOR INBORN ERRORS OF IMMUNITY WITH A FOCUS ON COMMON VARIABLE IMMUNODEFICIENCY (CVID) IN SPAIN: A COST-EFFECTIVENESS PERSPECTIVE
Mar 18, 2026, 21:38 PM -
EVALUATION OF AI-ASSISTED MULTI-ROW DATA EXTRACTION FOR META-ANALYSIS USING EASYSLR
Mar 18, 2026, 21:38 PM -
SOCIOECONOMIC BURDEN OF DRY EYE DISEASE IN THE UNITED STATES: REAL-WORLD EVIDENCE FROM THE ADELPHI DED DISEASE SPECIFIC PROGRAMME
Mar 18, 2026, 21:38 PM -
PREVALENCE AND SEVERITY OF ACNE VULGARIS IN FEMALE UNIVERSITY STUDENT ASSESSED FOR PCOS RISK
Mar 18, 2026, 21:38 PM -
U.S. REAL-WORLD PRESCRIBING PATTERNS OF MIXED GONADOTROPIN OVARIAN STIMULATION PROTOCOLS: A CLAIMS-BASED ANALYSIS
Mar 18, 2026, 21:38 PM -
FAST-TRACKED BUT FALLING SHORT? THERAPEUTIC VALUE AND POLICY ALIGNMENT OF FDA-APPROVED ANTIBIOTICS, 2010-2025
Mar 18, 2026, 21:38 PM -
APPLYING TARGET TRIAL EMULATION IN VACCINE RESEARCH: METHODOLOGICAL INSIGHTS AND REGULATORY IMPLICATIONS
Mar 18, 2026, 21:38 PM -
ACCOUNTING FOR RISK-AVERSION IN HEALTH TECHNOLOGY ASSESSMENT: UTILITY ESTIMATION ACROSS MULTIPLE HEALTH INDEXES IN NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
INSIGHTS INTO RANGE OF MOTION (ROM) AND PHYSICAL FUNCTION (PF) CHANGES EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: RESULTS FROM EXIT INTERVIEWS
Mar 18, 2026, 21:38 PM -
CONFIDENCE INTERVALS FOR EVENT-BASED NUMBER NEEDED TO TREAT: A PRACTICAL APPROACH FOR HEALTH ECONOMIC EVALUATION OUTPUTS
Mar 18, 2026, 21:38 PM -
ECONOMIC OUTCOMES, REAL-WORLD ADHERENCE PATTERNS AND PREDICTIVE MODELING OF MIGRAINE PROPHYLAXIS: A RETROSPECTIVE COHORT STUDY OF TRIPTANS, BETA-BLOCKERS, AND COMBINATION THERAPY
Mar 18, 2026, 21:38 PM -
ENSURING STUDY VALIDITY TO INFORM HEALTH TECHNOLOGY ASSESSMENTS GLOBALLY
Mar 18, 2026, 21:38 PM
